Phase II study of nilotinib plus pegylated interferon alfa-2b as first-line therapy in chronic phase chronic myeloid leukaemia aiming to maximize complete molecular response and major molecular response (CML11)
收藏Research Data Australia2024-12-14 收录
下载链接：
https://researchdata.edu.au/phase-ii-study-response-cml11/2538303
下载链接
链接失效反馈官方服务：
资源简介：
Dataset includes: Data for 60 patients with chronic phase CML, utilising nilotinib plus PEGylated interferon alfa-2b Diagnostic data, treatment data, outcome data Cancer Australia demographic data -Year of birth -Aboriginal or Torres Strait Islander status (or Ethnicity)
提供机构：
Health Data Australia Contributor Records
